全文获取类型
收费全文 | 17925篇 |
免费 | 1535篇 |
国内免费 | 305篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 381篇 |
妇产科学 | 17篇 |
基础医学 | 2565篇 |
口腔科学 | 236篇 |
临床医学 | 1754篇 |
内科学 | 5230篇 |
皮肤病学 | 331篇 |
神经病学 | 139篇 |
特种医学 | 394篇 |
外科学 | 1934篇 |
综合类 | 2219篇 |
现状与发展 | 3篇 |
预防医学 | 500篇 |
眼科学 | 109篇 |
药学 | 2000篇 |
7篇 | |
中国医学 | 1856篇 |
肿瘤学 | 70篇 |
出版年
2024年 | 51篇 |
2023年 | 427篇 |
2022年 | 657篇 |
2021年 | 742篇 |
2020年 | 753篇 |
2019年 | 756篇 |
2018年 | 728篇 |
2017年 | 765篇 |
2016年 | 701篇 |
2015年 | 573篇 |
2014年 | 1144篇 |
2013年 | 2133篇 |
2012年 | 893篇 |
2011年 | 990篇 |
2010年 | 717篇 |
2009年 | 818篇 |
2008年 | 782篇 |
2007年 | 830篇 |
2006年 | 695篇 |
2005年 | 576篇 |
2004年 | 509篇 |
2003年 | 357篇 |
2002年 | 358篇 |
2001年 | 294篇 |
2000年 | 276篇 |
1999年 | 267篇 |
1998年 | 251篇 |
1997年 | 191篇 |
1996年 | 191篇 |
1995年 | 167篇 |
1994年 | 143篇 |
1993年 | 144篇 |
1992年 | 122篇 |
1991年 | 85篇 |
1990年 | 92篇 |
1989年 | 59篇 |
1988年 | 54篇 |
1987年 | 58篇 |
1986年 | 64篇 |
1985年 | 59篇 |
1984年 | 61篇 |
1983年 | 33篇 |
1982年 | 61篇 |
1981年 | 39篇 |
1980年 | 24篇 |
1979年 | 19篇 |
1978年 | 14篇 |
1977年 | 13篇 |
1976年 | 11篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
《Journal of infection and chemotherapy》2022,28(4):587-590
A 37-year-old man developed right ankle pain and swelling six days after being diagnosed with coronavirus disease (COVID-19). Despite conservative treatment, his ankle symptoms persisted. Magnetic resonance imaging and computed tomography showed synovial hypertrophy and bone erosion in the ankle. Following arthroscopic synovectomy, performed 69 days after the COVID-19 diagnosis, the pain improved significantly. The clinical course was consistent with that of reactive arthritis following severe acute respiratory syndrome coronavirus 2 infection. The pathological findings resembled rheumatoid nodules. The bone erosion may have originated from the inflammatory pathway, which resembles the mechanism of rheumatoid arthritis. 相似文献
4.
Tofacitinib is an immunosuppressive and disease-modifying therapy in rheumatoid arthritis. It may result in many infections flaring up. It is important to take precautions of all kinds (cardiovascular, malignancy, infections etc.) before starting tofacitinib. In this article, we have highlighted important steps where we need to take precautions before starting tofacitinib. 相似文献
5.
6.
7.
8.
Peng Li Sha-Sha Tao Meng-Qin Zhao Jun Li Xiu Wang Hai-Feng Pan 《Immunological investigations》2015,44(7):603-615
Objective: Association of matrix metalloproteinases (MMPs) gene polymorphisms with rheumatoid arthritis is controversial. We conduct a meta-analysis to clarify this dispute.Methods: We systematically searched the electronic PUBMED, EMBASE and CNKI databases for research articles about MMPs (MMP-1, MMP-2, MMP-3, MMP-9) gene polymorphisms and rheumatoid arthritis (RA) up to January 2015. According to the heterogeneity, fixed-effects or random-effects models were used to calculate crude odds ratios (ORs) and 95% confidence intervals (95% CIs).Results: A total of 11 articles involving 2143 cases and 2049 controls were included in this meta-analysis. Overall, no significant associations were observed between MMP-1-1607 1G/2G polymorphism and RA. Stratification by ethnicity, no significant associations were observed in Caucasian populations. Similarly, no significant associations were observed between MMP-3-1171 5A/6A, MMP-9-1562 C/T polymorphisms and RA in overall and Caucasian populations, respectively. However, a weak association was found between MMP-2-1306 C/T polymorphism and RA (C vs. T, OR?=?0.813, 95%CI?=?0.694–0.953, p?=?0.010) in overall populations.Conclusions: The present meta-analysis suggests that MMP-1-1607 1G/2G, MMP-3-1171 5A/6A, MMP-9-1562 C/T polymorphisms are not associated with the susceptibility of RA, but MMP-2 -1306 C/T is weakly associated with susceptibility to RA. Further studies with more sample size are needed for definitive conclusions. 相似文献
9.
《Vaccine》2020,38(23):3934-3941
IntroductionSubjects with rheumatoid arthritis (RA) receiving tumor necrosis factor-inhibiting (TNFi) therapies are at risk for severe influenza, and may respond less well to influenza vaccine. We examined the safety and immunogenicity of high dose influenza vaccine (HD) compared to standard dose vaccine (SD) in participants with RA receiving stable TNFi.MethodsA randomized, double-blinded, Phase II study was conducted in adults with RA receiving TNFi, and healthy, gender and age-matched control subjects. Participants were immunized with HD (Sanofi Pasteur Fluzone High Dose [60 mcg × 3 strains]) or SD (Sanofi Pasteur Fluzone® [15 mcg × 3 strains]) intramuscularly (IM). A self-administered memory aid recorded temperature and systemic and local adverse events (AEs) for 8 days, and safety was evaluated and serum obtained to measure HAI activity on days 7, 21 and 180 days following vaccination.ResultsA greater proportion of RA subjects who received HD seroconverted at day 21 compared to SD, although this was not statistically significant. GMT antibody responses in RA subjects who received HD compared to SD were greater for all strains on day 21, and this was significant for H1N1. Seroconversion rates and GMT values were not different between RA subjects and control subjects. There were no safety concerns for HD or SD in RA subjects, and RA-related symptoms did not differ between SD and HD recipients by a RA-symptom questionnaire (RAPID 3).ConclusionsTNF-inhibitor therapy in people with RA did not appear to influence the immunogenicity of either SD or HD. Influenza seroconversion and GMT values were higher among RA subjects receiving HD compared to SD; however, differences were small and a larger study is needed to validate these findings. Given the apparent risk of increased influenza-related morbidity and mortality among immune compromised subjects, the higher GMT values generated by HD may be beneficial. 相似文献
10.